Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

Abstract

Preexisting immune response to SARS-CoV-2 Robust T cell responses to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus occur in most individuals with coronavirus disease 2019 (COVID-19). Several studies have reported that some people who have not been exposed to SARS-CoV-2 have preexisting reactivity to SARS-CoV-2 sequences. The immunological mechanisms underlying this preexisting reactivity are not clear, but previous exposure to widely circulating common cold coronaviruses might be involved. Mateus et al. found that the preexisting reactivity against SARS-CoV-2 comes from memory T cells and that cross-reactive T cells can specifically recognize a SARS-CoV-2 epitope as well as the homologous epitope from a common cold coronavirus. These findings underline the importance of determining the impacts of preexisting immune memory in COVID-19 disease severity. Science , this issue p. 89

Cited by papers we hold 42

• Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens · 2022
  Not checked
• Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19 · 2022
  Not checked
• Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein · 2022
  Not checked
• Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts · 2022
  No notice
• Adaptive Immune Responses and Immunity to SARS-CoV-2 · 2022
  No notice
• SARS-CoV-2 Variants, Vaccines, and Host Immunity · 2022
  No notice
• The COVID-19 pandemic is deepening the health crisis in South Kivu, Democratic Republic of Congo · 2021
  Not checked
• Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma · 2021
  Not checked
• Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection · 2021
  No notice
• Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 · 2021
  No notice
• Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination · 2021
  No notice
• SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells · 2021
  No notice
• COVID-19 Mechanisms in the Human Body—What We Know So Far · 2021
  Not checked
• Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level · 2021
  Not checked
• T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants · 2021
  Not checked
• The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic · 2021
  No notice
• SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection · 2021
  No notice
• Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 · 2021
  No notice
• T cell response to SARS-CoV-2 infection in humans: A systematic review · 2021
  No notice
• Immunological imprinting of the antibody response in COVID-19 patients · 2021
  No notice

and 22 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.